Evidence map›Paper›PMID 39281346›Full record

ArticleOne health (Amsterdam, Netherlands)2024

Multi-drug resistant (MDR) and extended-spectrum β-lactamase (ESBL) producing

Moise Matakone, Raspail Carrel Founou, Luria Leslie Founou, Brice Davy Dimani, Patrice Landry Koudoum, Marie Christine Fonkoua, Yap Boum-Ii, Hortense Gonsu, Michel Noubom

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in One health (Amsterdam, Netherlands), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Moise MatakoneDepartment of Microbiology- Haematology and Immunology, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.
Raspail Carrel FounouDepartment of Microbiology- Haematology and Immunology, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.
Luria Leslie FounouCameroonian Society for Microbiology, Yaoundé, Cameroon.
Brice Davy DimaniAntimicrobial Resistance and Infectious Disease (ARID) Research Unit, Research Institute of the Centre of Expertise and Biological Diagnostic of Cameroon (CEDBCAM-RI), Yaoundé, Cameroon.
Patrice Landry KoudoumDepartment of Microbiology- Haematology and Immunology, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.
Marie Christine FonkouaCameroonian Society for Microbiology, Yaoundé, Cameroon.
Yap Boum-IiCameroonian Society for Microbiology, Yaoundé, Cameroon.
Hortense GonsuCameroonian Society for Microbiology, Yaoundé, Cameroon.
Michel NoubomDepartment of Microbiology- Haematology and Immunology, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) in the food chain remains a global public health concern for both humans and animals. This study aimed to determine the prevalence, resistance profiles, and clonal relatedness of multidrug-resistant (MDR) and extended-spectrum β-lactamases- producing

Indexed as

ESBLEscherichia coliExposed workersMultidrug resistancePigs

Identifiers

PMID39281346
PMCPMC11402427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.